What's next for Securities America?

CEO Nagengast says firm sees ‘a lot of opportunity' for growth; snagged a Next Financial team in August

Nov 1, 2010 @ 2:26 pm

By Bruce Kelly

As broker-dealers continue to struggle with a lack of capital, Securities America Inc. sees plenty of opportunity to build its network of independent reps and advisers. And its CEO and president, Jim Nagengast, points to a direct competitor as a potential source.

In August, Steve Bull, a former branch manager with 20 reps under him at Next Financial Group Inc., joined Securities America. When asked about recruiting and mergers and acquisitions in an interview this morning, Mr. Nagengast said, “Next — we see a lot of opportunity there.”

Mr. Bull's group, Verus Capital Partners LLC, has about $225 million in assets under management, according to Securities America.

Barry Knight, CEO and president of Next Financial, did not return calls seeking comment.

In September, Securities America picked up another branch of about 45 reps and managers in control of $500 million in client assets formerly affiliated with Equitas America LLC. That firm is no longer operating as a broker-dealer, Securities America said.

Mr. Nagengast said that Securities America will look to make a couple of small acquisitions in 2011. “We're good at transitioning large branches quickly,” he said. “We're always looking. We're seeing more broker-dealers looking to shut down.”

Management and brokers at Securities America are enmeshed in legal battles stemming from the firm's sale of private placements up until 2008.

For more than a month, Securities America and the Massachusetts Securities Division have locked horns in Boston over the regulator's charges that the firm misled 60 investors in the state who bought $7.2 million in Medical Capital Holdings Inc. notes from the firm's reps.

That administrative hearing, which began in September, follows a January lawsuit in which Massachusetts regulators alleged that the firm failed to reveal potential red flags to advisers and clients about Medical Capital, which used the notes' proceeds to purchase medical receivables. The Securities and Exchange Commission in 2009 charged Medical Capital with fraud. The company is now in receivership.

Last week, Mr. Nagengast testified in the hearing pitting the Massachusetts regulator against Securities America. On Monday morning, he declined to comment about his testimony, saying, “We feel very strongly we did industry leading due diligence and are vigorously defending” the firm and its advisers.

0
Comments

What do you think?

View comments

Recommended for you

B-D Data Center

Use InvestmentNews' B-D Data Center to find exclusive information and intelligence about the independent broker-dealer industry.

Rank Broker-dealers by

Featured video

INTV

Why advisers are pessimistic about the economy

Deputy editor Bob Hordt and senior research analyst Matt Sirinides discuss a recent InvestmentNews survey of advisers, most of whom see a recession ahead before the next presidential election.

Recommended Video

Keys to a successful deal

Latest news & opinion

Finra focuses exam priorities on investor-protection threats

Online distribution of private placements pops up; exchange-traded products cause suitability worries.

10 public companies that boosted their ESG ratings in 2018

These 10 companies increased their environmental, social and governance scores last year.

Blackrock exposed data on 12,000 financial advisers

The data appeared in three spreadsheets, linked on one of the New York-based company's web pages dedicated to its iShares exchange-traded funds

Advisers throw cold water on FIRE movement

Millennials love it, advisers don't: Turns out, extreme early retirement is a suitable goal for almost nobody.

10 universities with the most billionaire alumni

These 10 American schools have the greatest number of alumni who are billionaires.

X

Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting investmentnews.com? It'll help us continue to serve you.

Yes, show me how to whitelist investmentnews.com

Ad blocker detected. Please whitelist us or give premium a try.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print